Zion Pharma - Crunchbase Company Profile & Funding

Q: Where is Zion Pharma's headquarters?

Zion Pharma is located in Shanghai, Shanghai, China.

Q: Who invested in Zion Pharma?

Zion Pharma has 8 investors including Med-Fine Capital And Ming Bioventures.

Q: When was the last funding round for Zion Pharma?

Zion Pharma closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Zion Pharma raised to date?

Zion Pharma has raised obfuscated.

Overview

Zion Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Zion Pharma

CB Rank

72638

Zion Pharma is a drug discovery platform.

Founded

obfuscation

Private

Series B

Shanghai, Shanghai, China

11-50

www.zionpharma.com

Biotechnology

Funding Rounds

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Ziqiang Cheng: Chairman, CEO & Founder
Ding Zhou: CSO & Co-Founder

Details

Legal Name

Zion Pharma Limited Hong Kong

Also Known As

赞荣医药, Zanrong Yiyao, Zion Pharma Hong Kong, Zanrong Medicine, Suzhou Zanrong Pharmaceutical Technology

Operating Status

Active

Company Type

For Profit

Founders

Ding Zhou, Ziqiang Cheng

About the Company

Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ZN-A-1041

An oral small molecule HER2-selective tyrosine kinase inhibitor designed to cross the blood-brain barrier for treating HER2-positive breast cancer brain metastases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B
obfuscated obfuscation	Series B - Zion Pharma	5	obfuscated obfuscation	OrbiMed	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Med-Fine Capital	—	Series B - Zion Pharma	Bai Yang
Med-Fine Capital	—	Series B - Zion Pharma	Bai Yang
Med-Fine Capital	—	Series B - Zion Pharma	Bai Yang
Med-Fine Capital	—	Series B - Zion Pharma	Bai Yang
Med-Fine Capital	—	Series B - Zion Pharma	Bai Yang